These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23196799)

  • 21. Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis.
    Ichikawa H; Yoshida A; Kanda T; Kosugi S; Ishikawa T; Hanyu T; Taguchi T; Sakumoto M; Katai H; Kawai A; Wakai T; Kondo T
    Cancer Sci; 2015 Jan; 106(1):115-24. PubMed ID: 25457157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of miR-133b predict progression and poor prognosis in patients with urothelial carcinoma of bladder.
    Chen X; Wu B; Xu Z; Li S; Tan S; Liu X; Wang K
    Cancer Med; 2016 Aug; 5(8):1856-62. PubMed ID: 27292588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PCAT6 mediates cellular biological functions in gastrointestinal stromal tumor via upregulation of PRDX5 and activation of Wnt pathway.
    Bai F; Zhang N; Fang W; He X; Zheng Y; Gu D
    Mol Carcinog; 2020 Jun; 59(6):661-669. PubMed ID: 32339330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
    Chen SW; Wang TB; Tian YH; Zheng YG
    Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The deregulation of miR-133b is associated with poor prognosis in bladder cancer.
    Shi Z; Kadeer A; Wang M; Wen B; Li M; Huang J; Gao Y; Liu E; Liu D; Jia D; Liang C
    Pathol Res Pract; 2019 Feb; 215(2):354-357. PubMed ID: 30591241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.
    Nagao Y; Hisaoka M; Matsuyama A; Kanemitsu S; Hamada T; Fukuyama T; Nakano R; Uchiyama A; Kawamoto M; Yamaguchi K; Hashimoto H
    Mod Pathol; 2012 Jan; 25(1):112-21. PubMed ID: 21983937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic Regulation of CD133 in Gastrointestinal Stromal Tumors.
    Geddert H; Braun A; Kayser C; Dimmler A; Faller G; Agaimy A; Haller F; Moskalev EA
    Am J Clin Pathol; 2017 May; 147(5):515-524. PubMed ID: 28398518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiRNA profiling of gastrointestinal stromal tumors by next-generation sequencing.
    Gyvyte U; Juzenas S; Salteniene V; Kupcinskas J; Poskiene L; Kucinskas L; Jarmalaite S; Stuopelyte K; Steponaitiene R; Hemmrich-Stanisak G; Hübenthal M; Link A; Franke S; Franke A; Pangonyte D; Lesauskaite V; Kupcinskas L; Skieceviciene J
    Oncotarget; 2017 Jun; 8(23):37225-37238. PubMed ID: 28402935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
    Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
    Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential Expression of
    Yuan J; Kihara T; Kimura N; Hashikura Y; Ohkouchi M; Isozaki K; Takahashi T; Nishida T; Ito A; Hirota S
    Pathol Oncol Res; 2021; 27():602008. PubMed ID: 34257559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors.
    Belinsky MG; Rink L; Flieder DB; Jahromi MS; Schiffman JD; Godwin AK; von Mehren M
    Genes Chromosomes Cancer; 2013 Feb; 52(2):214-24. PubMed ID: 23109135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HAND1 and BARX1 Act as Transcriptional and Anatomic Determinants of Malignancy in Gastrointestinal Stromal Tumor.
    Hemming ML; Coy S; Lin JR; Andersen JL; Przybyl J; Mazzola E; Abdelhamid Ahmed AH; van de Rijn M; Sorger PK; Armstrong SA; Demetri GD; Santagata S
    Clin Cancer Res; 2021 Mar; 27(6):1706-1719. PubMed ID: 33451979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression.
    Tang CM; Lee TE; Syed SA; Burgoyne AM; Leonard SY; Gao F; Chan JC; Shi E; Chmielecki J; Morosini D; Wang K; Ross JS; Kendrick ML; Bardsley MR; Siena M; Mao J; Harismendy O; Ordog T; Sicklick JK
    Oncotarget; 2016 Nov; 7(48):78226-78241. PubMed ID: 27793025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant DNA methylation associated with aggressiveness of gastrointestinal stromal tumour.
    Okamoto Y; Sawaki A; Ito S; Nishida T; Takahashi T; Toyota M; Suzuki H; Shinomura Y; Takeuchi I; Shinjo K; An B; Ito H; Yamao K; Fujii M; Murakami H; Osada H; Kataoka H; Joh T; Sekido Y; Kondo Y
    Gut; 2012 Mar; 61(3):392-401. PubMed ID: 21708825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of microRNA-133b and its target gene FSCN1 in gastric cancer.
    Guo L; Bai H; Zou D; Hong T; Liu J; Huang J; He P; Zhou Q; He J
    J Exp Clin Cancer Res; 2014 Nov; 33(1):99. PubMed ID: 25433493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strong association of fascin expression with triple negative breast cancer and basal-like phenotype in African-American women.
    Esnakula AK; Ricks-Santi L; Kwagyan J; Kanaan YM; DeWitty RL; Wilson LL; Gold B; Frederick WA; Naab TJ
    J Clin Pathol; 2014 Feb; 67(2):153-60. PubMed ID: 23986556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors.
    Koelz M; Lense J; Wrba F; Scheffler M; Dienes HP; Odenthal M
    Int J Oncol; 2011 Feb; 38(2):503-11. PubMed ID: 21132270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synchronous and metachronous multiple gastrointestinal stromal tumors.
    Xu C; Liu YL; Yu HY; Hou YY; Lu SH; Zhao LJ; Zhou Y; Shi Y; Tan YS; Zhu XZ
    Histol Histopathol; 2012 Feb; 27(2):225-34. PubMed ID: 22207557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-320a downregulation is associated with imatinib resistance in gastrointestinal stromal tumors.
    Gao X; Shen K; Wang C; Ling J; Wang H; Fang Y; Shi Y; Hou Y; Qin J; Sun Y; Qin X
    Acta Biochim Biophys Sin (Shanghai); 2014 Jan; 46(1):72-5. PubMed ID: 24217767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of low-density lipoprotein receptor class A domain containing 4 (LDLRAD4) as a prognostic indicator in primary gastrointestinal stromal tumors.
    Xie W; Xiao H; Luo J; Zhao L; Jin F; Ma J; Li J; Xiong K; Chen C; Wang G
    Curr Probl Cancer; 2020 Dec; 44(6):100593. PubMed ID: 32507364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.